Discover Ono Pharmaceutical's groundbreaking patent for autophagy-inhibiting compounds, targeting various cancers with innovative MEK inhibitors like selumetinib.

Geoffrey D. Young, MD, PhD, FACS, discussed the many advances in thyroid cancer management and treatment, highlighting what a ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

After hours: September 23 at 4:01 PM EDT ...

近年来随着治疗靶点的发现和新型靶向药物的不断研发，肿瘤治疗已步入精准治疗新时代。近日，2024 年世界肺癌大会（WCLC）和欧洲肿瘤内科学会（ESMO）年会陆续召开，带来肿瘤领域最新前沿进展。会议中，针对 BRAF、MET 14 ...

RPE-1 cells adapt to aneuploidy in vitro, a process characterized by reduced CIN and inflammation. This study shows that this ...

Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University, in collaboration with the ...

After hours: September 20 at 6:10 PM EDT Loading Chart for VSTM ...